左旋多巴吸收的变化。一例帕金森病患者在接受治疗剂量左旋多巴后血浆多巴浓度升高的报告。 - Suppr | 超能文献

Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.

作者信息

Granerus A K, Jagenburg R, Rödjer S, Svanborg A

出版信息

Acta Med Scand. 1974 Dec;196(6):459-63.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.左旋多巴吸收的变化。一例帕金森病患者在接受治疗剂量左旋多巴后血浆多巴浓度升高的报告。

Acta Med Scand. 1974 Dec;196(6):459-63.

2

Intestinal decarboxylation of orally administered L-dopa. Influence of pharmacological preparations, dose magnitude, dose sequence and food intake.口服左旋多巴的肠道脱羧作用。药理制剂、剂量大小、给药顺序和食物摄入的影响。

Acta Med Scand. 1975 Nov;198(5):415-20.

3

[Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].左旋多巴与外周多巴脱羧酶抑制剂联合治疗帕金森病——13例临床病程及血清/多巴和多巴胺水平

Rinsho Shinkeigaku. 1976 Jul 1;16(7):511-9.

4

[Results of determination of plasma methoxydopa in parkinsonian patients with or without dyskinesia induced by L-Dopa].[左旋多巴诱导或未诱导运动障碍的帕金森病患者血浆甲氧基多巴的测定结果]

Rev Neurol (Paris). 1977 Nov;133(11):627-36.

5

Intermittent levodopa therapy in parkinsonism.

Adv Neurol. 1983;37:45-50.

6

Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.帕金森病患者急性摄入左旋多巴后的同型半胱氨酸水平。

Mov Disord. 2009 Jul 15;24(9):1339-43. doi: 10.1002/mds.22607.

7

Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.

Clin Chem. 2001 Jun;47(6):1102-4.

8

CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.帕金森病患者脑脊液和血浆中游离去甲肾上腺素、多巴胺、3,4-二羟基苯乙酸（DOPAC）、3,4-二羟基苯丙氨酸（DOPA）及肾上腺素的浓度

Acta Neurol Scand. 1995 Aug;92(2):116-21. doi: 10.1111/j.1600-0404.1995.tb01023.x.

9

[Long-term l-DOPA therapy for parkinsonism and its pathochemical aspect].

Zh Nevropatol Psikhiatr Im S S Korsakova. 1977;77(12):1810-3.

10

Peculiarities of L: -DOPA treatment of Parkinson's disease.左旋多巴治疗帕金森病的特点。

Amino Acids. 2005 Mar;28(2):157-64. doi: 10.1007/s00726-005-0162-4. Epub 2005 Mar 9.

引用本文的文献

1

Systemic activity of orally administered L-dopa in the elderly Parkinson patient.老年帕金森病患者口服左旋多巴的全身活性

Eur J Clin Pharmacol. 1980;17(3):215-21. doi: 10.1007/BF00561903.

2

Anti-parkinsonian drugs today.当今的抗帕金森病药物。

Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.